Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study.

OBJECTIVE To determine risk factors for pediatric hospital-associated venous thromboembolism (HA-VTE) in noncritically ill children to derive a novel HA-VTE risk model for this population. STUDY DESIGN Patients with HA-VTE were identified retrospectively via the electronic health record at All Children's Hospital Johns Hopkins Medicine from April 10, 2013 through January 1, 2006. Seven contemporaneous, noncritically ill control children were randomly selected for each case of HA-VTE. The association between putative risk factors and HA-VTE was estimated with ORs and 95% CIs, which were calculated using the Wald method. A P-value threshold ≤.2 was used in univariate analysis for inclusion into a multivariate (adjusted) model. RESULTS Fifty cases of HA-VTE occurred in noncritically ill children. The presence of a central venous catheter (OR 27.67, 95% CI, 8.40-91.22), infection (OR 10.40, 95% CI, 3.46-31.25), and length of stay ≥4 days (OR 5.26, 95% CI, 1.74-15.88) were found to be statistically significant risk factors for HA-VTE. An 8-point risk score was derived in which scores of 8 points, 7 points, and ≤6 points corresponded to venous thromboembolism risks of 12.5%, 1.1%, and 0.1%, respectively. CONCLUSION The presence of a central venous catheter, infection, and length of stay ≥4 days are significant risk factors for HA-VTE in noncritically ill children, forming the basis for a new risk score that could inform venous thromboembolism prophylaxis decision-making. These findings warrant prospective validation.

[1]  M. Manco‐Johnson,et al.  Sensitivity of discharge diagnosis ICD-9 codes for pediatric venous thromboembolism is greater than specificity, but still suboptimal for surveillance and clinical research. , 2012, Thrombosis research.

[2]  S. Israels,et al.  Outcome of Pediatric Thromboembolic Disease: A Report from the Canadian Childhood Thrombophilia Registry , 2000, Pediatric Research.

[3]  B. McCrindle,et al.  A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. , 2011, Journal of the American College of Cardiology.

[4]  L. Brandão,et al.  Clinical features and outcome of pulmonary embolism in children , 2008, British journal of haematology.

[5]  P. Stein,et al.  Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. , 2004, The Journal of pediatrics.

[6]  P. Mourani,et al.  Risk factors for in-hospital venous thromboembolism in children: a case-control study employing diagnostic validation , 2012, Haematologica.

[7]  E. Kuhn,et al.  Incidence and Risk Factors for Venous Thromboembolism in Critically Ill Children With Cardiac Disease , 2011, Pediatric Cardiology.

[8]  M. Valsecchi,et al.  Screening for Coagulopathy and Identification of Children With Acute Lymphoblastic Leukemia at a Higher Risk of Symptomatic Venous Thrombosis: An AIEOP Experience , 2013, Journal of pediatric hematology/oncology.

[9]  G. Guyatt,et al.  Physicians Evidence-Based Clinical Practice Development : American College of Chest Thrombolytic Therapy Guideline Methodology for Antithrombotic and , 2008 .

[10]  A. Rademaker,et al.  Risk‐prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds‐Clot clinical Decision Rule , 2012, Journal of thrombosis and haemostasis : JTH.

[11]  L. Raffini,et al.  Thromboprophylaxis in a Pediatric Hospital: A Patient-Safety and Quality-Improvement Initiative , 2011, Pediatrics.

[12]  P. Mourani,et al.  Cardiac findings and long-term thromboembolic outcomes following pulmonary embolism in children: a combined retrospective-prospective inception cohort study , 2012, Cardiology in the Young.

[13]  S. Kahn,et al.  Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors , 2010, Haematologica.

[14]  A. Turpie,et al.  Predictive and associative models to identify hospitalized medical patients at risk for VTE. , 2011, Chest.

[15]  C. Feudtner,et al.  Dramatic Increase in Venous Thromboembolism in Children's Hospitals in the United States From 2001 to 2007 , 2009, Pediatrics.

[16]  M. Haumer,et al.  Incidence of thrombotic and bleeding complications during cardiac catheterization in children: comparison of high‐dose vs. low‐dose heparin protocols , 2011, Journal of thrombosis and haemostasis : JTH.

[17]  Elie A Akl,et al.  Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis , 9 th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines , 2013 .

[18]  P. Simpson,et al.  Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma , 2012, The journal of trauma and acute care surgery.

[19]  Sybil A. Klaus,et al.  Hospital-associated venous thromboembolism in children: incidence and clinical characteristics. , 2014, The Journal of pediatrics.